SequelSEC

HWH International Inc. HWH

Wholesale-Drugs, Proprietaries & Druggists' Sundries · CIK 0001897245 · Fiscal year ends 1231

Revenue
$866.93K
Fiscal year ended 2025-12-31
Operating income
Unavailable
Fiscal year ended 2025-12-31
Free cash flow
-$1.77M
Fiscal year ended 2025-12-31

Valuation, from the filing

Public float$2.02MMarket value of stock held by non-affiliates, as stated on the cover page for 2025-07-01
Float per share$0.27Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself.
Float / revenue2.3×A lower bound on the multiple, because affiliate holdings are excluded.
Float / equity0.8×A lower bound on the multiple, because affiliate holdings are excluded.

Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-07-01, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.

How this compares in its industry

Percentile among the Wholesale-Drugs, Proprietaries & Druggists' Sundries filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.

MeasureReportedPercentile
Current ratio2.32x100th
FCF margin-204.1%0th
Revenue YoY growth-30.8%12th
CapEx / revenue2.2%86th
Net margin-303.4%14th
SBC / revenue182.3%83th
Gross margin53.0%62th

HWH International Inc. (HWH) reported revenue of $866.93K and net income of -$2.63M for the fiscal year ended 2025-12-31. This page shows 3 annual periods of income statement, balance sheet and cash flow figures normalized from HWH International Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Wholesale-Drugs, Proprietaries & Druggists' Sundries.

Income

HWH International Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Revenue$866.93K$1.25M$1.18K
Cost of revenue$407.20K$651.72KUnavailable
Gross profit$459.73K$601.86KUnavailable
Operating incomeUnavailableUnavailableUnavailable
Net income-$2.63M-$2.75M-$1.08M
Research & developmentUnavailableUnavailableUnavailable
Weighted-average diluted sharesshares 6.56Mshares 3.61MUnavailable
Pretax income-$2.61M-$2.77M-$661.28K
Income tax expense$47.47KUnavailable$415.38K
Diluted EPS$-0.40$-0.76Unavailable
Selling, general & administrativeUnavailableUnavailableUnavailable
General & administrative$3.53M$2.81M$2.91M
Selling & marketingUnavailableUnavailableUnavailable

Balance

HWH International Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Cash & equivalents$2.09M$4.34M$1.16M
Total assets$4.57M$6.41M$23.71M
Current assets$2.97M$5.47M$1.34M
Total liabilitiesUnavailableUnavailableUnavailable
Current liabilities$1.28M$3.31M$6.02M
Total equity incl. NCI$2.68M$2.88M-$3.60M
Temporary (mezzanine) equityUnavailableUnavailable$21.10M
Inventory$1.06K$1.57K$1.98K
Accounts receivable$3.32K$17.55K$28.61K
Goodwill$116.65K$0Unavailable
Long-term debtUnavailableUnavailableUnavailable
Accounts payableUnavailableUnavailableUnavailable

Cash flow

HWH International Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Operating cash flow-$1.75M-$1.82M-$2.60M
Capital expenditures$19.46K$30.39K$14.57K
Investing cash flow-$1.19M$20.45M$68.43M
Financing cash flow$934.71K-$15.60M-$67.46M
Net change in cashUnavailableUnavailableUnavailable
Stock-based compensation$1.58MUnavailableUnavailable
Common dividends paidUnavailableUnavailableUnavailable
Common share repurchasesUnavailable$21.10M$68.35M
Depreciation & amortization$19.49K$48.17KUnavailable

Derived

HWH International Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2025-12-312024-12-312023-12-31
Free cash flow-$1.77M-$1.85M-$2.61M
Gross margin53.0%48.0%41866.0%
Operating marginUnavailableUnavailableUnavailable
FCF margin-204.1%-147.6%-220856.8%
SBC / revenue182.3%UnavailableUnavailable
Current ratio2.32x1.65x0.22x
Revenue YoY growth-30.8%105776.4%Unavailable
Net margin-303.4%-219.4%-91257.8%
R&D / revenueUnavailableUnavailableUnavailable
CapEx / revenue2.2%2.4%1230.9%
Long-term debt / equityUnavailableUnavailableUnavailable
Effective tax rateUnavailableUnavailableUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open HWH in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-07-30View SEC filing
10-Q · Filed 2026-05-13View SEC filing
10-K · Filed 2026-03-26View SEC filing
10-Q · Filed 2025-10-22View SEC filing
10-Q · Filed 2025-08-14View SEC filing
10-Q · Filed 2025-05-15View SEC filing

Companies in the same industry

Reconciliation checks needing review

1 period on this page do not reconcile under this site’s normalization. Read that as a limitation here before an observation about the company: the figures are the filer’s own, the filings linked above are authoritative, and a difference usually means the concepts this site selected do not match how this filer presents its statements. Nothing is adjusted to make a check pass.

gross profit bridgeinconsistent2023-12-31

Withheld: cost revenue, gross profit could not be reconciled with the rest of this filer’s statement.